TIAA FSB’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

TIAA FSB’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-53,194	Closed	-$507K	–	321
2019 Q1	$507K	Sell	53,194 -2,500	-4%	-$25.5K	﹤0.01%	299
2018 Q4	$639K	Buy	+55,694	New	+$692K	﹤0.01%	288

Other funds holding SGMO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TIAA FSB's SGMO Position: Q2 2019 in Review

TIAA FSB sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 53,194 shares — an estimated $507K sold.

TIAA FSB first reported a position in SGMO in Q4 2018 and held it in 2 quarters. The position peaked at $639K in Q4 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

TIAA FSB reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
TIAA FSB sold 53,194 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $507K.
TIAA FSB first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 2 quarters.
TIAA FSB's SANGAMO THERAPEUTICS INC position peaked at $639K in Q4 2018.
185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on TIAA FSB's 13F filing for Q2 2019, filed 14 Aug 2019.